Tyra Biosciences, Inc. 10-Q

Item 5 . Other Information None. 74 Item 6 . Exhibits Exhibit Number Exhibit Description Incorporated by Reference Filed Herewith Form Date Number 3.1 Amended and Restated Certificate of Incorporation 8-K 9/17/21 3.1 3.2 Amended and Restated Bylaws 8-K 9/17/21 3.2 4.1 Specimen stock certificate evidencing the shares of common stock S-1 8/20/21 4.1 4.2 Amended and Restated Investors’ Rights Agreement, dated March 5, 2021, by and among the Registrant and certain of its stockholders S-1/A 9/9/21 4.2 10.1# Tyra Biosciences, Inc. 2021 Incentive Award Plan and form of stock option grant notice and stock option agreement thereunder S-1/A 9/9/21 10.2 10.2# Tyra Biosciences, Inc. 2021 Employee Stock Purchase Plan S-1/A 9/9/21 10.3 10.3# Non-Employee Director Compensation Program S-1/A 9/9/21 10.4 10.4# Second Amended and Restated Employment Letter Agreement, dated August 18, 2021, by and between Todd Harris and the Registrant S-1 8/20/21 10.12 10.5# Second Amended and Restated Employment Letter Agreement, dated August 18, 2021, by and between Daniel Bensen and the Registrant S-1 8/20/21 10.13 10.6# Amended and Restated Employment Letter Agreement, dated August 18, 2021, by and between Esther van den Boom and the Registrant S-1 8/20/21 10.14 10.7# Amended and Restated Employment Letter Agreement, dated August 18, 2021, by and between Ronald Swanson and the Registrant S-1 8/20/21 10.15 10.8# Amended and Restated Employment Letter Agreement, dated August 18, 2021, by and between Hiroomi Tada and the Registrant S-1 8/20/21 10.16 10.9# Amended and Restated Employment Agreement, dated August 18, 2021, by and between Robert Hudkins and the Registrant S-1 8/20/21 10.17 10.10# Amended and Restated Employment Letter Agreement, dated August 18, 2021, by and between Piyush Patel and the Registrant S-1 8/20/21 10.18 10.11# Form of Indemnification Agreement for Directors and Officers S-1 8/20/21 10.20 31.1 Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 31.2 Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 32.1* Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 32.2* Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 101.INS Inline XBRL Instance Document X 101.SCH Inline XBRL Taxonomy Extension Schema Document X 101.CAL Inline XBRL Taxonomy Calculation Linkbase Document X 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document X 101.LAB Inline XBRL Taxonomy Label Linkbase Document X 101.PRE Inline XBRL Presentation Linkbase Document X 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) X # Indicates management contract or compensatory plan. * This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act. 75 SIG NATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. TYRA BIOSCIENCES, INC. Date: November 3, 2021 By: /s/ Todd Harris, Ph.D. Todd Harris, Ph.D. President, Chief Executive Officer, and Director (Principal Executive Officer) Date: November 3, 2021 By: /s/ Esther van den Boom Esther van den Boom Chief Financial Officer (Principal Financial and Accounting Officer) 76